Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study
Author:
Funder
National Research Council of Thailand
Publisher
Frontiers Media SA
Subject
General Medicine
Reference22 articles.
1. Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions;Schett;Ann Rheum Dis.,2016
2. A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study;Hirata;Rheumatology.,2013
3. Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study;Hafström;BMJ Open.,2014
4. Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power doppler synovitis activity and clinical disease activity are well controlled;Kawashiri;Arthritis Res Therapy.,2017
5. The proportion of regulatory T cells in patients with rheumatoid arthritis: a meta-analysis;Morita;PLoS ONE.,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Human embryonic stem cell–derived mesenchymal stromal cells suppress inflammation in mouse models of rheumatoid arthritis and lung fibrosis by regulating T-cell function;Cytotherapy;2024-08
2. Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission;Nature Communications;2024-02-05
3. Qingre Lishi Decoction ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice by regulating the Treg-DC-Th17 axis and inhibiting MAPK-mediated DC maturation;Journal of Ethnopharmacology;2024-01
4. Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial;Frontiers in Immunology;2022-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3